Published on in Vol 10, No 3 (2022): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39186, first published .
Breathing as an Input Modality in a Gameful Breathing Training App (Breeze 2): Development and Evaluation Study

Breathing as an Input Modality in a Gameful Breathing Training App (Breeze 2): Development and Evaluation Study

Breathing as an Input Modality in a Gameful Breathing Training App (Breeze 2): Development and Evaluation Study

Journals

  1. Boesch M, Baty F, Rassouli F, Kowatsch T, Joerger M, Früh M, Brutsche M. Non-pharmaceutical interventions to optimize cancer immunotherapy. OncoImmunology 2023;12(1) View
  2. Castro O, Mair J, Salamanca-Sanabria A, Alattas A, Keller R, Zheng S, Jabir A, Lin X, Frese B, Lim C, Santhanam P, van Dam R, Car J, Lee J, Tai E, Fleisch E, von Wangenheim F, Tudor Car L, Müller-Riemenschneider F, Kowatsch T. Development of “LvL UP 1.0”: a smartphone-based, conversational agent-delivered holistic lifestyle intervention for the prevention of non-communicable diseases and common mental disorders. Frontiers in Digital Health 2023;5 View
  3. Jeong H, Yoo J, Goh M, Song H. Deep breathing in your hands: designing and assessing a DTx mobile app. Frontiers in Digital Health 2024;6 View
  4. Brasier N, Frobert O, De Ieso F, Meyer D, Kowatsch T, Ghaffari R. The potential of wearable sweat sensors in heart failure management. Nature Electronics 2024;7(3):182 View
  5. Schläpfer S, Schneider F, Santhanam P, Eicher M, Kowatsch T, Witt C, Barth J. Engagement With a Relaxation and Mindfulness Mobile App Among People With Cancer: Exploratory Analysis of Use Data and Self-Reports From a Randomized Controlled Trial. JMIR Cancer 2024;10:e52386 View
  6. Salamanca-Sanabria A, Liew S, Mair J, De Iorio M, Ling Y, Tint M, Wei Y, Lim K, Ong D, Chooi Y, Tay V, Eriksson J. A holistic lifestyle mobile health intervention for the prevention of type 2 diabetes and common mental disorders in Asian women with a history of gestational diabetes: a randomised control trial with 3-year follow-up protocol. Trials 2024;25(1) View